Home Cart Sign in  
Chemical Structure| 2370013-49-1 Chemical Structure| 2370013-49-1

Structure of (S)-Sunvozertinib
CAS No.: 2370013-49-1

Chemical Structure| 2370013-49-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

(S)-Sunvozertinib , the S-enantiomer of Sunvozertinib, shows inhibitory activity against EGFR exon 20 NPH and ASV insertions, EGFR L858R/T790M mutation and Her2 exon20 YVMA insertion. (S)-Sunvozertinib also inhibits BTK

Synonyms: (S)-DZD9008; DZD9008; Sunvozertinib

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of (S)-Sunvozertinib

CAS No. :2370013-49-1
Formula : C29H35ClFN7O3
M.W : 584.08
SMILES Code : C=CC(NC1=CC(NC2=NC=CC(NC3=CC(Cl)=C(F)C=C3C(C)(O)C)=N2)=C(OC)C=C1N4C[C@@H](N(C)C)CC4)=O
Synonyms :
(S)-DZD9008; DZD9008; Sunvozertinib
MDL No. :MFCD34603702

Safety of (S)-Sunvozertinib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H361
Precautionary Statements:P501-P202-P201-P264-P280-P302+P352-P308+P313-P337+P313-P305+P351+P338-P362+P364-P332+P313-P405

Related Pathways of (S)-Sunvozertinib

RTK
JAK-STAT

Isoform Comparison

Biological Activity

Description
(S)-Sunvozertinib ((S)-DZD9008), the S-enantiomer of Sunvozertinib), exhibits inhibitory activity against EGFR exon 20 NPH and ASV insertions, EGFR L858R/T790M mutation, and Her2 exon20 YVMA insertion (with IC50 values of 51.2 nM, 51.9 nM, 1 nM, and 21.2 nM, respectively). Additionally, (S)-Sunvozertinib inhibits BTK[1].
Target
  • EGFR/ErbB1

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.71mL

0.34mL

0.17mL

8.56mL

1.71mL

0.86mL

17.12mL

3.42mL

1.71mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories